The Global Fund to Fight AIDS, TB & Malaria

Description

The Global Fund is a partnership between governments, civil society, the private sector, and people affected by AIDS, tuberculosis (TB), and malaria. Its goal is to end these diseases as epidemics.

What Does This Buy?

Funds support HIV prevention, treatment of HIV, TB, and malaria, antiretroviral therapy, identifying missing TB cases, diagnostics, healthcare worker training, and building resilient and sustainable health systems.

Justification for the Request

• Increased funding will support the Global Fund’s Sixth Replenishment, which runs from 2020 to 2022.
• A contribution of $1.56 billion for the first installment of the Sixth Replenishment of the Global Fund will continue U.S. leadership and encourage other donors to increase their investment. For its Sixth Replenishment the Global Fund has projected that between FY 2020-2022 a minimum of $14 billion is needed to achieve its strategy goals and get on track to end the three epidemics.
• The Global Fund has saved 27 million lives by decreasing AIDS, TB, and malaria-related deaths.
• The Global Fund provided 17.5 million people infected with HIV antiretroviral therapy in 2017. It provides 65% of the global financing for TB and has distributed 795 million mosquito nets since 2002.
• Every $100 million invested in the Global Fund:
  • Saves 133,000 lives,
  • Averts 1.9 million new HIV, TB, and malaria infections,
  • Provides antiretroviral therapy for 107,000 people,
  • Provides treatment for 31,000 women to prevent passing HIV to their babies,
  • Provides TB treatment and care for 153,000 people,
  • Provides 4,300 people with treatment for multidrug-resistant TB,
  • Distributes 6.2 million mosquito nets to protect children and families from malaria,
  • Provides indoor residual spraying for 1.2 million households to protect families from mosquitoes,
  • Spurs implementing countries’ domestic investment of $300 million toward the three diseases, and
  • Creates $2.2 billion in long-term economic gain.
• AIDS, TB, and malaria claim more than 2.5 million lives annually, over half a million of which are children.

U.S. Interest

Funding global health supports U.S. national security by developing the capacity around the world to prevent, detect, and respond to dangerous outbreaks of diseases that have the potential to pose an immediate and significant threat to the health and safety of Americans.

Bold Vision

As Africa’s young population is projected to double by 2050, institutions must keep up with demand to prevent new cases of AIDS, TB, and malaria from expanding through vulnerable populations.

Impact of Cuts

• Cuts could jeopardize programs that encourage full regimens, potentially allowing drug-resistant strains of AIDS, TB, and malaria to create an epidemic resurgence.
• Cuts could debilitate effective U.S. bilateral efforts such as PEPFAR, whose impact benefits from the Global Fund and threaten a reversal of current progress.